Kala Pharmaceuticals Inc (KALA) Insider Trading
- $112,097,301.57
- $1,932,784.32
- June 3, 2025
- Orbimed Advisors Llc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| July 25, 2017 | Insider | 319,333 | $15.00 | Buy | $4,789,995.00 | |
| July 20, 2017 | Major Shareholder | 215,000 | $15.00 | Buy | $3,225,000.00 |
Insiders are both buying and selling Kala Pharmaceuticals Inc stock.
The insider traders at Kala Pharmaceuticals Inc are: Orbimed Advisors Llc, Mark T Iwicki, Todd Bazemore, Mary Reumuth, Eric Trachtenberg, Darius Kharabi, Ra Capital Management, L.P., Rajeev M Shah, Romulus K Brazzell, Hongming Chen, Bros. Advisors Lp Baker, Ra Capital Healthcare Fund Lp, Associates L.L.C. Cdk, Howard B Rosen, Longitude Capital Partners Ii,, Mark T. Iwicki, and Gregory Grunberg
The most active insider trader at Kala Pharmaceuticals Inc is Orbimed Advisors Llc with 10 trades.
Ra Capital Management, L.P. has sold the most Kala Pharmaceuticals Inc stock with a total value of $2,017,487.56.
Rajeev M Shah has bought the most Kala Pharmaceuticals Inc stock with a total value of $107,999,985.30.
The most recent insider trade for Kala Pharmaceuticals Inc was on June 3, 2025.
The single biggest insider buy for Kala Pharmaceuticals Inc was from Rajeev M Shah with a total value of $49,999,995.15 on March 13, 2020.
The single biggest insider sell for Kala Pharmaceuticals Inc was from Ra Capital Management, L.P. with a total value of $812,500.00 on May 23, 2022.